Literature DB >> 23939643

Cluster headache.

Jacqueline Weaver-Agostoni1.   

Abstract

Cluster headache causes severe unilateral temporal or periorbital pain, lasting 15 to 180 minutes and accompanied by autonomic symptoms in the nose, eyes, and face. Headaches often recur at the same time each day during the cluster period, which can last for weeks to months. Some patients have chronic cluster headache without remission periods. The pathophysiology of cluster headache is not fully understood, but may include a genetic component. Cluster headache is more prevalent in men and typically begins between 20 and 40 years of age. Treatment focuses on avoiding triggers and includes abortive therapies, prophylaxis during the cluster period, and long-term treatment in patients with chronic cluster headache. Evidence supports the use of supplemental oxygen, sumatriptan, and zolmitriptan for acute treatment of episodic cluster headache. Verapamil is first-line prophylactic therapy and can also be used to treat chronic cluster headache. More invasive treatments, including nerve stimulation and surgery, may be helpful in refractory cases.

Entities:  

Mesh:

Year:  2013        PMID: 23939643

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  7 in total

1.  Population-Based Analysis of Cluster Headache-Associated Genetic Polymorphisms.

Authors:  Martha-Spyridoula Katsarou; Maria Papasavva; Rozana Latsi; Ioanna Toliza; Alfrent-Pantelis Gkaros; Stylianos Papakonstantinou; Stylianos Gatzonis; Dimos-Dimitrios Mitsikostas; Leda Kovatsi; Boris N Izotov; Aristides M Tsatsakis; Nikolaos Drakoulis
Journal:  J Mol Neurosci       Date:  2018-06-29       Impact factor: 3.444

Review 2.  Cluster Headache: A Review and Update in Treatment.

Authors:  Himanshu Suri; Jessica Ailani
Journal:  Curr Neurol Neurosci Rep       Date:  2021-05-05       Impact factor: 5.081

3.  New Verapamil Analogs Inhibit Intracellular Mycobacteria without Affecting the Functions of Mycobacterium-Specific T Cells.

Authors:  Getahun Abate; Peter G Ruminiski; Malkeet Kumar; Kawaljit Singh; Fahreta Hamzabegovic; Daniel F Hoft; Christopher S Eickhoff; Asmir Selimovic; Mary Campbell; Kelly Chibale
Journal:  Antimicrob Agents Chemother       Date:  2015-12-07       Impact factor: 5.191

4.  Sildenafil can induce the onset of a cluster headache bout.

Authors:  Guan-Yu Lin; Jiunn-Tay Lee; Giia-Sheun Peng; Fu-Chi Yang
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

5.  Multicentre, prospective, randomised, controlled, blinded-endpoint study to evaluate the efficacy and safety of pterygopalatine ganglion pulsed radiofrequency treatment for cluster headache: study protocol.

Authors:  Jin Li; Hao Ren; Baoguo Wang; Dasheng Wu; Fang Luo
Journal:  BMJ Open       Date:  2019-03-23       Impact factor: 2.692

Review 6.  Pharmacogenetics in Primary Headache Disorders.

Authors:  Irina I Belyaeva; Anna G Subbotina; Ivan I Eremenko; Vadim V Tarasov; Vladimir N Chubarev; Helgi B Schiöth; Jessica Mwinyi
Journal:  Front Pharmacol       Date:  2022-02-10       Impact factor: 5.810

7.  Manual therapy and exercise for patients with cluster headache.

Authors:  Lucía de-la-Puente-Ranea; Alfonso Gil-Martínez; Oscar Rodríguez-Lopez; Pablo González-Gutiérrez; Maria Ángeles Mangas-Guijarro; Gonzalo Navarro-Fernández
Journal:  EXCLI J       Date:  2021-05-25       Impact factor: 4.068

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.